bioRxiv · 10.1101/2025.05.16.654579
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer
Abstract
Metastasis remains the leading cause of cancer-related mortality, yet predicting future metastasis is a major clinical challenge due to the lack of validated biomarkers and effective assessment methods. Here, we present EmitGCL, a deep-learning framework that accurately predicts future metastasis and its corresponding biomarkers. Based on a comprehensive benchmarking comparison, EmitGCL outperformed other computational tools across six cancer types from seven cohorts of patients with superior sensitivity and specificity. It captured occult metastatic cells in a patient with a lymph node-negative breast cancer, who was declared to have no evidence of disease by conventional imaging methods but was later confirmed to have a metastatic disease. Notably, EmitGCL identified HSP90AA1 and HSP90AB1 as predictable biomarkers for future breast cancer metastasis, which was validated across five independent cohorts of patients (n=420). Furthermore, we demonstrated YY1 transcription factor as a key driver of breast cancer metastasis which was validated through in-silico and CRISPR-based migration assays, suggesting that YY1 is a potential therapeutic target for deterring metastasis.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Ma, Q., Wang, X., Duan, M., Su, P.-L., Li, J., Krull, J., Jin, J., Chen, H., Sun, Y., Wu, W., He, K., Carpenter, R., Zhang, C., Cao, S., Xu, D., Wang, G., Li, L., Xin, G., Carbone, D. P., Li, Z.. 2025-05-22. Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer. https://doi.org/10.1101/2025.05.16.654579
Cite the original work for its findings. Save a collection to share your selection of sources.